Dr. Eirwen M. Miller

"Thomas Krivak, MD is the director of the Ovarian Cancer Center of Excellence and co-chair of the Society of Gynecologic Oncology Research Institute. He specializes in treating ovarian, uterine and other gynecologic cancers and has particular expertise in minimally invasive surgical techniques, as well as non-invasive options. Dr. Krivak received his medical degree at Ohio State University College of Medicine and performed his residency at David Grant Medical Center, Travis Air Force Base in California. He completed his fellowship at the Walter Reed Army Medical Center in Washington, DC and at the National Cancer Institute, Rockville, Maryland. Dr. Krivak is board-certified by the American Boards of Obstetrics and Gynecology and Gynecologic Oncology. He was named one of Pittsburgh Magazine's ""Best Doctors"" in 2019.". Dr. Krivak is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Vulvar Cancer, Hernia Surgery, and Salpingo-Oophorectomy. Dr. Krivak is board certified in American Board Of Obstetrics And Gynecology - Gynecologic Oncology.

Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.

Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.